Researchers from Cardiff University in the UK have described a new type of T cell receptor (TCR) that has been shown in laboratory studies to recognise and kill many human cancer types while ignoring healthy cells. T cells equipped with the new TCR were able to kill a host of malignancies including lung, skin, blood and colon cancers in mice engineered with human cancers and a human immune system. The research was published on 20 January 2020 in the journal Nature Immunology.
